article thumbnail

Baylor wins 2024 STAT Madness with ‘smoke alarm’ for viral disease outbreaks

STAT

Their study demonstrating the power of sewage as an early-warning system for outbreaks won the 2024 STAT Madness popular vote. Building off that early polio work from the 1940s, researchers from the Baylor College of Medicine analyzed public wastewater and showed they could detect over 450 disease-causing viruses. Read the rest…

354
354
article thumbnail

Listen: Live! From JPM 2024

STAT

Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. Recording from the J.P. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit. Read the rest…

218
218
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

JPM Healthcare Conference 2024

STAT

8-11, 2024 — setting the stage for the rest of the year in health, science, and medicine. The annual J.P. Morgan Healthcare Conference, the largest event of its kind, will take place in San Francisco, Jan. The event is a gathering space for investors, entrepreneurs, and others. 8 looking at what’s next in biotech.

246
246
article thumbnail

Biotech layoffs, slumping stocks, and a 2024 preview

STAT

And what’s going to move markets in 2024? We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Why are rich biotechs cutting costs? Has JPM Week already worn off? Read the rest…

247
247
article thumbnail

STAT+: 3 trends to watch in biotech in 2024

STAT

But after two years of steady decline, 2024 might finally prove them right. Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

303
303
article thumbnail

STAT+: 3 CRISPR advances to watch in 2024

STAT

Here are three CRISPR developments we’re watching in 2024: Continue to STAT+ to read the full story… The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

310
310
article thumbnail

Meet the contenders for the STAT Madness 2024 crown. Voting begins March 1

STAT

The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers.

333
333